GlassScriptPhysician profile
Harold J Schock
NPI 1316143787
$314,187.00
in general payments reported to CMS, 2019-2025
8 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $696 · 2020: $277K · 2021: $43.10 · 2022: $36K · 2024: $28.16 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $185.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $309,721.34 | 2020-2022 | |
| Arthrex, INC. | $3,494.18 | 2019-2020 | |
| Smith+Nephew, INC. | $354.05 | 2019 | |
| Great Lakes Orthopedics | $324.93 | 2020 | |
| Stryker Corporation | $157.04 | 2025 | Blueprint Patient Specific Instrumentation |
| Pacira Therapeutics, INC. | $107.30 | 2019-2021 | |
| Bioventus LLC | $28.16 | 2024 | Gelsyn-3 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$839,116.63 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Schock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.